Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Diabetologia
|
November 28, 2009
The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study
F-Y Hsiao, C D Mullins
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|
January 1, 1996
What are outcomes?
C D Mullins, R Baldwin, E M Perfetto
Pharmacoeconomics
|
January 9, 2001
Cost effectiveness of abciximab during routine medical practice
S O Reed, C D Mullins, L S Magder
Chest
|
March 13, 2001
The direct medical costs of alpha(1)-antitrypsin deficiency
C D Mullins, X Huang, S Merchant, et al.
Health Affairs (Project Hope)
|
September 18, 2001
The impact of pipeline drugs on drug spending growth
C D Mullins, J Wang, F B Palumbo, et al.
Journal of Comparative Effectiveness Research
|
June 4, 2021
What works when: mapping patient and stakeholder engagement methods along the ten-step continuum framework
Hillary A Edwards, Jennifer Huang, Liz Jansky, et al.
Clinical Therapeutics
|
December 16, 2000
Indirect cost of HIV infection in England
C D Mullins, G Whitelaw, J L Cooke, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
September 9, 1999
Direct health care costs for treatment of diabetes mellitus and hypertension in an IPA-group-model HMO
S P Amin, C D Mullins, B S Duncan, et al.
Clinical Therapeutics
|
December 1, 2001
Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitis
E M Perfetto, C D Mullins, P Subedi, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 24, 1998
Difficulties in applying clinical trial information to the practice setting: case of a high-cost drug
S D Reed, C D Mullins, D S Roffman, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Diabetologia
|
November 28, 2009
The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study
F-Y Hsiao, C D Mullins
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|
January 1, 1996
What are outcomes?
C D Mullins, R Baldwin, E M Perfetto
Pharmacoeconomics
|
January 9, 2001
Cost effectiveness of abciximab during routine medical practice
S O Reed, C D Mullins, L S Magder
Chest
|
March 13, 2001
The direct medical costs of alpha(1)-antitrypsin deficiency
C D Mullins, X Huang, S Merchant, et al.
Health Affairs (Project Hope)
|
September 18, 2001
The impact of pipeline drugs on drug spending growth
C D Mullins, J Wang, F B Palumbo, et al.
Journal of Comparative Effectiveness Research
|
June 4, 2021
What works when: mapping patient and stakeholder engagement methods along the ten-step continuum framework
Hillary A Edwards, Jennifer Huang, Liz Jansky, et al.
Clinical Therapeutics
|
December 16, 2000
Indirect cost of HIV infection in England
C D Mullins, G Whitelaw, J L Cooke, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
September 9, 1999
Direct health care costs for treatment of diabetes mellitus and hypertension in an IPA-group-model HMO
S P Amin, C D Mullins, B S Duncan, et al.
Clinical Therapeutics
|
December 1, 2001
Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitis
E M Perfetto, C D Mullins, P Subedi, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 24, 1998
Difficulties in applying clinical trial information to the practice setting: case of a high-cost drug
S D Reed, C D Mullins, D S Roffman, et al.
Page
of 4